Skip to content

Search

Dr Mary Abraham wins national diabetes research award

Congratulations to Dr Mary Abraham from the Rio Tinto Children's Diabetes Centre and Perth Children's Hospital, who has been awarded the prestigious Australian Diabetes Society (ADS) Lindsey Baudinet Rising Star Award in T1D Research.

Join our nutrition videos

Would you like to help teach others with diabetes? The team at the Rio Tinto Children’s Diabetes Centre are creating nutrition education videos for children and their parents living with type 1 diabetes.

Hybrid Closed-Loop Versus Manual Insulin Delivery in Adults With Type 1 Diabetes: A Post Hoc Analysis Using the Glycemia Risk Index

Glycemia risk index (GRI) is a novel composite metric assessing overall glycemic risk, accounting for both hypoglycemia and hyperglycemia and weighted toward extremes. Data assessing GRI as an outcome measure in closed-loop studies and its relation with conventional key continuous glucose monitoring (CGM) metrics are limited.

An Assessment of Clinical Continuous Glucose Monitoring Targets for Older and High-Risk People Living with Type 1 Diabetes

To assess relationships between continuous glucose monitoring (CGM) time in range (TIR), 70-180 mg/dL, time below range (TBR), <70 mg/dL, time above range (TAR), >180 mg/dL, and glucose coefficient of variation (CV) in relation to currently recommended clinical CGM targets for older people, which recommend reduced TIR and TBR targets relative to the general type 1 diabetes population. 

A very low carbohydrate diet for minimising blood glucose excursions during ultra-endurance open-water swimming in type 1 diabetes: a case report

Carbohydrate-restricted diets are used by people with type 1 diabetes (T1D) to help manage their condition. However, the impact of this strategy on blood glucose responses to exercise is unknown. This study describes the nutritional strategies of an athlete with T1D, who follows a very low carbohydrate diet to manage her condition during an ultra-endurance open-water swimming event. 

Clinical Outcomes with MiniMedTM 780G Advanced Hybrid Closed-Loop Therapy in 2- to 6-Year-Old Children with Type 1 Diabetes

Advanced hybrid closed-loop (AHCL) therapy with the Medtronic MiniMed™ 780G system improves glycemia; however, the clinical outcomes in younger children remain less established. This pilot study aimed to explore the continuous glucose monitoring (CGM) metrics in very young children on AHCL. Children between 2 and 7 years of age and on insulin pump therapy were recruited.

New study: Managing T1D During Exercise in High-Level Athletes

The aim of this study is to describe the strategies used by competitive athletes with T1D to successfully manage their condition during sport and exercise.

JDRF one talk with Prof Liz Davis

JDRF ONE TALK WITH... PROFESSOR LIZ DAVIS  Tune into JDRF Australia instagram page Wednesday 20 October from 3PM WST to hear our Co-Director Professor Liz Davis chat about the diabetes research she's involved in and why she does it. JDRF Australia (@jdrfaus) • Instagram photos and videos

Looking at the Big Food Picture For T1D

Kids with diabetes should think beyond just carbs, according to The Kids Research Institute Australia senior dietitian Dr Amelia Harray.